The effects of hexoprenaline, a β2-sympathomimetic drug, on maternal glucose, insulin, glucagon, and free fatty acid levels
- 1 April 1978
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 130 (7) , 761-764
- https://doi.org/10.1016/0002-9378(78)90005-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Use of a β2-sympathomimetic drug as a temporizing measure in the treatment of acute fetal distressAmerican Journal of Obstetrics and Gynecology, 1977
- The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.Journal of Clinical Investigation, 1976
- Gastric Inhibitory Polypeptide (GIP) in Chronic PancreatitisJournal of Clinical Endocrinology & Metabolism, 1976
- Metabolic responses to selective β-adrenergic stimulation in manPublished by Oxford University Press (OUP) ,1975
- Glucagon Secretion from the Perfused Rat Pancreas STUDIES WITH GLUCOSE AND CATECHOLAMINESJournal of Clinical Investigation, 1974
- Stimulation of Glucagon Secretion by Epinephrine in ManJournal of Clinical Endocrinology & Metabolism, 1973
- STUDY OF FETAL AND MATERNAL INSULIN LEVELS DURING LABOURBJOG: An International Journal of Obstetrics and Gynaecology, 1968
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967
- The colorimetric micro-determination of non-esterified fatty acids in plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 1964